Over the last three years, increasing numbers of adaptor molecules that contain the caspase recruitment domain (CARD) have been identified.CARD was originally described as a protein-binding motif that interacts with caspase through a CARD-CARD interaction.However, CARD has now also been found in many adaptor proteins that do not interact with caspase, but mediate the assembly of CARD-containing proteins in apoptosis and NF-κB signaling.Apoptotic signaling is controlled by homo-and heterophilic interactions between CARD-containing molecules: Caspases exist as inactive zymogens, and are activated through interactions with adaptor molecules that contain CARD.CARD-containing molecules are also involved in the regulation of gene expression that is involved in cell survival and immune responses through NF-κB activation.Therefore, this report will describe the function and signaling cascade of recently identified CARD-containing proteins in apoptosis and NF-κB activation.CARD-containing molecules were divided into two major groups, based on their functional interactions with caspase and NF-κB signals (Fig. 1 and Table 1). CARD-adaptor in NF-κB activation Frequent mutation in tumors affecting NF-κB activation and apoptosisBcl10/CLAP/CIPER/mE10/CARMEN Bcl10 was recently cloned from the chromosome translocation t (1; 14) (p22; q32) in MALT B cell lymphoma.Inactivating mutations and the over-expression of Bcl10 were also frequently found in the lymphoid tumor of the B or T cell lineage, as well as cell lines that are derived from solid tumor types (Fakruddin et al.,
No takes yet. Share an insight, caveat, or question.
Hong et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: